Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor

Tilman M Hackeng1, Kristin M Seré, Guido Tans

  • 1Department of Biochemistry, Cardiovascular Research Institute Maastricht, University of Maastricht, The Netherlands. t.hackeng@bioch.unimaas.nl

Insights

Protein S enhances tissue factor pathway inhibitor (TFPI) activity, promoting factor Xa inhibition. This discovery reveals a new mechanism for regulating blood clotting and suggests protein S deficiency increases thrombosis risk.

Area of Science:

  • Biochemistry
  • Hematology
  • Molecular Biology

Background:

  • Tissue factor (TF) is crucial in hemostasis, inflammation, and disease.
  • Protein S is a known cofactor for activated protein C.
  • The regulation of TF-driven coagulation is complex.

Purpose of the Study:

  • To elucidate a novel mechanism of TF activity inhibition.
  • To investigate the role of protein S in TF pathway inhibitor (TFPI) function.
  • To understand the implications of protein S in thrombosis.

Main Methods:

  • Biochemical assays to measure TFPI and FXa interactions.
  • Kinetic analysis of TFPI-FXa complex formation in the presence and absence of protein S.
  • Evaluation of TFPI efficacy at physiological concentrations.

Main Results:

  • Protein S specifically enhances TFPI's inhibition of factor Xa (FXa).
  • Protein S reduces the inhibition constant (K(i)) of the FXa/TFPI complex by 10-fold (from 4.4 nM to 0.5 nM).
  • This enhancement makes TFPI effective at plasma-relevant concentrations, accelerating feedback inhibition of TF-mediated coagulation.

Conclusions:

  • Protein S and TFPI act synergistically to inhibit TF activity.
  • This mechanism provides a new perspective on regulating TF-induced thrombin generation.
  • Protein S deficiency may increase thrombosis risk by impairing both the protein C system and TFPI-mediated anticoagulation.

Related Concept Videos

Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...